XML 19 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common stock
Additional paid-in capital
Treasury stock at cost
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance at Dec. 31, 2017   $ 2 $ 15,293 $ (21,892) $ 13,929 $ 717
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased/forfeited   0        
Common stock and stock-based awards issued     9      
Tax withholdings related to net share settlements of restricted stock units and awards     (60)      
Stock-based compensation     120      
Other     0      
Common stock repurchased       (1,011)    
Net income $ 407       407  
Dividends and dividend equivalents declared         0  
Other         (1)  
Foreign currency translation adjustment (36)         132
Change in unrealized gains (losses) on investments           (36)
Change in unrealized gains (losses) on derivative instruments           (29)
Tax benefit (provision) on above items           16
Ending balance at Mar. 31, 2018 $ 7,596 2 15,362 (22,903) 14,335 800
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0          
Beginning balance at Dec. 31, 2018 $ 6,281 2 15,716 (26,394) 16,459 498
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased/forfeited   0        
Common stock and stock-based awards issued     3      
Tax withholdings related to net share settlements of restricted stock units and awards     (54)      
Stock-based compensation     121      
Other     (1)      
Common stock repurchased (1,500)     (1,501)    
Net income 518       518  
Dividends and dividend equivalents declared         (130)  
Other         0  
Foreign currency translation adjustment 40         (32)
Change in unrealized gains (losses) on investments           40
Change in unrealized gains (losses) on derivative instruments           (41)
Tax benefit (provision) on above items           (1)
Ending balance at Mar. 31, 2019 $ 5,203 $ 2 $ 15,785 $ (27,895) $ 16,847 $ 464
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.14